ESC Premium Access

Antithrombotic therapy in patients with atrial fibrillation undergoing PCI – Represented in NEJM by the PIONEER-AF PCI trial and the RE-DUAL PCI trial

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Congress Presentation

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

3 more presentations in this session

Antithrombotic therapy in stable cardiovascular disease - Represented in NEJM by the COMPASS trial and the PEGASUS-TIMI 54 trial

Speaker: Doctor J. Eikelboom (Hamilton, CA)


Fractional Flow Reserve-Guided PCI – represented in NEJM by the FAME, FAME-2, Compare-Acute, IFR-SWEDEHEART, and DEFINE-FLAIR trials

Speaker: Professor E. Barbato (Rome, IT)


PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

Speaker: Professor L. Soendergaard (Copenhagen, DK)


Access the full session

Highlights from the New England Journal of Medicine: Editors’ Choice

Speakers: Professor C. Cannon, Doctor J. Eikelboom, Professor E. Barbato, Professor L. Soendergaard

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb